Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03291184
Other study ID # EN_GC_2017
Secondary ID
Status Completed
Phase N/A
First received September 19, 2017
Last updated April 9, 2018
Start date September 4, 2017
Est. completion date March 8, 2018

Study information

Verified date March 2018
Source Onze Lieve Vrouw Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to describe the incidence of postoperative residual paralysis (mean train-of-four <90%) when weaning from the ventilator in patients admitted to the Intensive Care Unit (ICU) after elective cardiac surgery. Train-of-four monitoring is a widely used term for the peripheral nerve stimulation used in neuromuscular blockade monitoring. When the patient is ready for weaning from the ventilator, an ICU doctor will perform a measurement of the train-of-four at the thumb with a neuromuscular transmission monitor. Every value below 90% will be considered as residual paralysis and treated appropriately by means of a reversal agent.


Description:

Postoperatively, in the ICU, readiness-for-weaning is based on ICU doctor-nurse-driven institutional weaning guidelines: 6 hours after arrival in the ICU, a patient who is normothermic, hemodynamically stable, has normal blood gasses and absence of residual bleeding. The ICU nurse caring for the patient will start weaning the patient from the ventilator, following these departmental guidelines.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date March 8, 2018
Est. primary completion date January 2, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- patients admitted to the ICU after elective cardiac surgery

Exclusion Criteria:

- emergency cardiac surgery

Study Design


Related Conditions & MeSH terms

  • Delayed Emergence from Anesthesia
  • Postoperative Residual Curarization

Intervention

Device:
peripheral neuromuscular monitor
Residual paralysis can only be measured by neuromuscular transmission monitoring of a peripheral nerve, typically the ulnar nerve innervating the adductor pollicis muscle.

Locations

Country Name City State
Belgium OLV Hospital Aalst

Sponsors (1)

Lead Sponsor Collaborator
Onze Lieve Vrouw Hospital

Country where clinical trial is conducted

Belgium, 

References & Publications (3)

Cammu G. How rational is muscle relaxation during cardiac surgery? Acta Anaesthesiol Belg. 2007;58(1):7-14. — View Citation

Rudis MI, Guslits BG, Zarowitz BJ. Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit. Ann Pharmacother. 1996 Feb;30(2):165-72. Review. — View Citation

Videira RL, Vieira JE. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs? Anesth Analg. 2011 Nov;113(5):1192-6. doi: 10.1213/ANE.0b013e31822c986e. Epub 2011 Aug 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative residual curarisation mean train-of-four <90% as measured by neuromuscular blockade monitoring 6 hours after arrival in the ICU
See also
  Status Clinical Trial Phase
Completed NCT05003024 - Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Sugammadex N/A
Recruiting NCT00753389 - Muscle Relaxants and Post-Anesthesia Complications N/A
Completed NCT03804346 - Infantile - Postoperative Residual Curarization - Study
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Recruiting NCT05760560 - Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
Completed NCT05224648 - Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Neostigmine N/A
Completed NCT03665805 - Postoperative Residual Curarization in 2018
Completed NCT01651572 - Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia Phase 4
Completed NCT03219138 - Algorithm of Muscle Function Tests to Detect Residual Neuromuscular Blockade. N/A
Completed NCT02697929 - Sugammadex/Neostigmine and Liver Transplantation N/A
Recruiting NCT03923556 - Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery Phase 4
Not yet recruiting NCT03460509 - Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery Phase 4
Recruiting NCT05051371 - Postoperative Residual Curarization in Elderly Patients in Post-anesthesia Care Unit